International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 5 of the 68 sources its claims cite were checked for support.
Abstract
In the accompanying comment letter (1), Weinert summarizes published data from the Brazilian Gestational Diabetes Study (2) and comments on applying International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel recommendations (3) for the diagnosis of gestational diabetes mellitus (GDM) to that cohort. The Brazilian study provided evidence that adverse perinatal outcomes are associated with levels of maternal glycemia below those diagnostic of GDM by American Diabetes Association or World Health Organization criteria. However, the results were potentially confounded by the treatment of GDM. It did find that women with GDM were at increased risk for some …
Overview
CoChat Summary
## TL;DR
This IADPSG consensus report recommends new gestational diabetes mellitus (GDM) diagnostic thresholds based on HAPO study data, using a 75-g OGTT and outcome-linked glucose cutoffs. It also recommends early detection of overt diabetes in pregnancy and notes that these recommendations will increase the frequency of diagnosed hyperglycemic disorders in pregnancy.
## Key findings
- In the HAPO study, a 75-g OGTT was performed in a heterogeneous, multinational, multicultural, ethnically diverse cohort of approximately 25,000 women in the third trimester; medical caregivers were blinded unless predefined glucose criteria were exceeded.
- The report states that the HAPO data showed continuous, graded associations between maternal glucose and primary outcomes, with no obvious thresholds; associations were also observed for secondary outcomes and did not differ among centers.
- The recommended diagnostic thresholds correspond to glucose levels where odds for birth weight >90th percentile, cord C-peptide >90th percentile, and percent body fat >90th percentile reached 1.75 times the estimated odds at mean glucose values; by these criteria, FPG alone identified 8.3% of the HAPO cohort, FPG plus 1-hour glucose identified an additional 5.7%, and 2-hour glucose another 2.1%, for a total GDM incidence of 17.8%.
- Among the HAPO cohort, 11.1% had only one elevated result, 3.9% had two elevated results, 1.1% had all three elevated, and 1.7% were unblinded because FPG or 2-hour glucose exceeded 5.8 mmol/l (105 mg/dl) or 11.1 mmol/l (200 mg/dl).
## Methods
- Consensus report based on review of the HAPO study, additional unpublished HAPO findings, and other published studies discussed at a June 2008 IADPSG workshop/meeting in Pasadena, followed by consensus panel deliberation.
- HAPO design described as observational: a 75-g OGTT in a large multinational cohort, with blinded caregivers except for preset safety thresholds.
- Thresholds were derived from fully adjusted logistic regression models relating continuous maternal glucose measures (FPG, 1-hour, 2-hour) to outcomes; the panel selected an odds ratio threshold of 1.75 relative to mean glucose values.
## Limitations
- The paper states that recommendations for detecting overt diabetes during pregnancy are based on the opinions of the IADPSG Consensus Panel because prospective studies or appropriately designed clinical trials were not available.
- It states that it was not determined whether universal early testing for overt diabetes is clinically valuable or cost-effective.
- Evident from the text: the HAPO study was observational, not a clinical trial, so the diagnostic thresholds are inferred from associations rather than randomized intervention effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 0 Not valid · 36 Not checked · 22 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Similar associations were also observed for secondary outcomes (25,26).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
The Abstract of our copy states that the predefined primary outcomes (size at birth, cesarean delivery, neonatal hypoglycemia, fetal hyperinsulinemia) were reported elsewhere, and that this report's goals were to examine maternal glycemia against additional/newborn anthropometric outcomes (sum of skin folds, individual skin folds, percent body fat) plus cord C-peptide. The Results report strong, graded, continuous associations for these outcomes (e.g., ORs 1.33–1.47 for percent body fat >90th percentile and 1.28–1.56 for individual skin folds), and the Discussion explicitly says 'This pattern is similar to that reported for maternal glucose and birth weight >90th percentile.' That covers the claim's substance — similar associations for the secondary/additional outcomes — even though the paper does not use the label 'secondary outcomes'. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Associations of LGA and excess adiposity with fetal hyperinsulinemia are strong and independent of confounders (26,37,38).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
What the sources say
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
In the Results (Table 5), higher cord C-peptide, the paper’s measure of fetal insulin, is strongly associated with birth weight above the 90th percentile and adiposity measures. The Discussion states that the relationships persisted after adjustment for potential confounders. The paper does not claim that every possible confounder was excluded. (LLM, conf=0.92)
- Not checked yetcites [37] Metzger BE Silverman BL Freinkel N Dooley SL Ogata ES Green OC: Amniotic fluid insulin concentration as a predictor of obesity. Arch Dis Child 1990; 65: 1050– 1052 2241225 PMC1590256 source
- Not checked yetcites [38] Weiss PA Haeusler M Tamussino K Haas J: Can glucose tolerance test predict fetal hyperinsulinism? BJOG 2000; 107: 1480– 1485 11192103 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Although not directly comparable, it was concluded that results of the two randomized controlled trials (47,48) and HAPO (25,26) are highly complementary.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM > Other considerations
What the sources say
- Supportedcites [47] Crowther CA Hiller JE Moss JR McPhee AJ Jeffries WS Robinson JS: Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477– 2486 15951574 source
The paper identifies itself as a randomized clinical trial and reports its treatment results (secondary outcomes; page unavailable). In the citing sentence, this citation identifies one of the two trials whose results are being discussed; it does not attribute the cross-study judgment of complementarity to this trial paper. (LLM, conf=0.88)
- Not checked yetcites [48] Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B Wapner RJ Varner MW Rouse DJ Thorp JM Jr Sciscione A Catalano P Harper M Saade G Lain KY Sorokin Y Peaceman AM Tolosa JE Anderson GB: Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009: 361; 1339– 1348. PMC2804874 19797280
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Could not verifycites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 sourceExperimental — accuracy not yet measured
The Abstract reports HAPO findings on maternal glucose and pregnancy outcomes, but does not compare them with randomized trials. Searches for randomized trials and for the claimed complementarity found no passage in our copy making that comparison. No page numbers were available. (LLM, conf=0.70)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“Importantly, there were continuous graded relationships between higher maternal glucose and increasing frequency of the primary outcomes, independent of other risk factors (25).”
- Also stated in: § Future considerations · boosted
“The HAPO study was a basic epidemiological investigation that for the first time conclusively identified strong continuous associations of maternal glucose levels below those diagnostic of diabetes with several perinatal outcomes.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Future considerations · boosted
None of the sources cited for this claim have been checked yet.
In the paper
“HAPO data show strong linear associations of risks for >90th percentiles of birth weight, cord C-peptide, and percent body fat with each of three measures of maternal glucose (FPG, 1-h, and 2-h post–75-g load).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 62 claims and to verify the 63 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GDM was identified when fasting blood glucose (FBG) ≥ 5.1 mmol/L during the first trimester or any plasma glucose after a 75 g OGTT performed as: FBG ≥ 5.1 mmol/L, 1 h after glucose load ≥ 10.0 mmol/L or 2 h after glucose load ≥ 8.5 mmol/L using the criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) [28].”
From Associations of maternal pre-pregnancy BMI and gestational weight gain with the risks of adverse pregnancy outcomes in Chinese women with gestational diabetes mellitus (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“to adopt diagnostic glucose thresholds corresponding to a HAPO OR of 1.75 (fasting plasma glucose [FPG] 5.1–6.9 mmol/L, one‐hour plasma glucose [1hPG] ≥ 10.0 mmol/L, and/or two‐hour plasma glucose [2hPG] 8.5–11.0 mmol/L). 14”
From Australasian Diabetes in Pregnancy Society ( ADIPS ) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes (2025) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The IADPSG diagnostic thresholds are the first criteria based on risks of adverse perinatal outcomes, rather than risk of subsequent development of maternal diabetes1 or by applying thresholds that define impaired glucose tolerance outside of pregnancy.5,6”
From Gestational Diabetes Mellitus (2019) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“following the diagnostic criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) (18)”
From Diabetes gestacional y riesgo de apnea obstructiva del sueño en el tercer trimestre (2025) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Based on the HAPO Study and other studies, new criteria for the diagnosis of gestational diabetes were proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) 2 and adopted by the World Health Organization and others.3,4”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [2]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303 · cited 2×
“Long-term risks associated with fetal macrosomia in infants of women with GDM (independent of confounders) include childhood overweight (43,44) and metabolic factors that may increase risk of cardiovascular disease (CVD) (45).”
BackgroundA Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
(1964) · PubMed · Cited by 1,230
Research works printed but not linked: 2
- Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Health Canada 1994; 15– 23
- National Collaborating Centre for Women's and Children's Health. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London, U.K., RCOG Press, 2008 21370515
Cited by
Items 601–700 of 1,132
Olagbuji, B. N., Atiba, A. S., Olofinbiyi, B. A., Akintayo, A. A., Awoleke, J. O., Ade-Ojo, I. P., & Fasubaa, O. B. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.02.030 · Cited by 69
High iron level in early pregnancy increased glucose intolerance
Zein, S., Rachidi, S., Awada, S., Osman, M., Al‐Hajje, A., Shami, N., Sharara, I., Cheikh-Ali, K., Salameh, P., & Hininger‐Favier, I. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.09.004 · Cited by 64
Frøslie, K. F., Røislien, J., Qvigstad, E., Godang, K., Bollerslev, J., Voldner, N., Henriksen, T., & Veierød, M. B. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-6 · Cited by 60
Zhang, Y., Zhang, H., Lu, J., Zheng, S., Long, T., Li, Y., Wu, W., & Wang, F. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12484 · Cited by 61
Elevated levels of chemerin, leptin, and interleukin-18 in gestational diabetes mellitus
Fatima, S. S., Alam, F., Chaudhry, B., & Khan, T. A. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1199671 · Cited by 61
Sweeting, A., Appelblom, H., Ross, G. P., Wong, J., Kouru, H., Williams, P. F., Sairanen, M., & Hyett, J. A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.02.036 · Cited by 67
Aris, I. M., Bernard, J. Y., Chen, L.-W., Tint, M. T., Pang, W. W., Soh, S., Saw, S., Shek, L. P., Godfrey, K. M., Gluckman, P. D., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.178 · Cited by 68
“1 mmol/L (International Association of the Diabetes and Pregnancy Study Groups criteria(32)); duration of any breastfeeding: <4 months; and early introduction of solid foods: <4 months(33).”
Cost-effectiveness of controlling gestational diabetes mellitus: a systematic review
Fitria, N., van Asselt, A. D. I., & Postma, M. J. (2019) · The European Journal of Health Economics · doi:10.1007/s10198-018-1006-y · Cited by 58
McIntyre, D. H., Kapur, A., Divakar, H., & Hod, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.614533 · Cited by 73
Risk factor screening for gestational diabetes mellitus based on the 2013 WHO criteria
Benhalima, K., Van Crombrugge, P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., De Block, C., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0117 · Cited by 60
Pathirana, M. M., Lassi, Z. S., Alì, A., Arstall, M. A., Roberts, C. T., & Andraweera, P. H. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09587-0 · Cited by 65
Kurt, B., Gürlek, B., Keskin, S., Özdemir, S., Karadeniz, Ö., Kırkbir, İ. B., Kurt, T., Ünsal, S., Kart, C., Baki, N., et al. (2023) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-023-02800-7 · Cited by 71
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
Waugh, N., Royle, P., Clar, C., Henderson, R., Cummins, E., Hadden, D., Lindsay, R., & Pearson, D. (2010) · Health Technology Assessment · doi:10.3310/hta14450 · Cited by 60
Diagnosis of gestational diabetes
Coustan, D. R. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.936677 · Cited by 65
Diabetes in pregnancy among First Nations women in Alberta, Canada: a retrospective analysis
Oster, R. T., King, M., Morrish, D. W., Mayan, M. J., & Toth, E. L. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-136 · Cited by 59
Battista, M.-C., Hivert, M.-F., Duval, K., & Baillargeon, J.-P. (2011) · Experimental Diabetes Research · doi:10.1155/2011/596060 · Cited by 55
Asistencia a la gestante con diabetes. Guía de práctica clínica actualizada en 2014
Acosta, D., Balsells, M., Ballesteros, M., Bandrés, O., Bartha, J. L., Bellart, J., Chico, A. I., Codina, M., Corcoy, R., Cortázar, A., et al. (2015) · Avances en Diabetología · doi:10.1016/j.avdiab.2014.12.001 · Cited by 80
Black, M. H., Zhou, H., Sacks, D. A., Dublin, S., Lawrence, J. M., Harrison, T. N., & Reynolds, K. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000855 · Cited by 60
“OGTT results were used to identify women with GDM based on recent International Association of Diabetes in Pregnancy Study Group guidelines (at least one OGTT value: fasting >92mg/dl, 1 h >180 mg/dl, 2 h>153 mg/dl) [26].”
MethodLi, H., Yin, Q., Li, N., OuYang, Z., & Zhong, M. (2016) · Obstetrics and Gynecology International · doi:10.1155/2016/3865454 · Cited by 63
Is first-trimester HbA1c useful in the diagnosis of gestational diabetes?
Benaiges, D., Roux, J. A. F., Marcelo, I., Mañé, L., Rodríguez, M. Á., Navarro, X., Chillarón, J. J., Llauradó, G., Gortazar, L., Pedro‐Botet, J., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.019 · Cited by 64
Cade, T. J., Polyakov, A., & Brennecke, S. P. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-023293 · Cited by 59
“Primary outcomes were those on which the new criteria were based, namely caesarean section rates, hypertensive disorder of pregnancy, birth weight greater than the 90th percentile, preterm birth less than 37 weeks.(2) Additional maternal outcomes were induction of labour, instrumental birth, third degree tear and post…”
BackgroundMethodSesmilo, G., Prats, P., Garcia, S., Rodríguez, I., Rodríguez-Melcón, A., Berges, I., & Serra, B. (2020) · Acta Diabetologica · doi:10.1007/s00592-019-01474-8 · Cited by 60
Liu, B., Cai, J., Xu, Y., Long, Y., Deng, L., Lin, S., Zhang, J., Yang, J., Zhong, L., Luo, Y., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa633 · Cited by 58
Climate factors and gestational diabetes mellitus risk – a systematic review
Preston, E. V., Eberle, C., Brown, F. M., & James-Todd, T. M. (2020) · Environmental Health · doi:10.1186/s12940-020-00668-w · Cited by 65
“Table 1 Gestational diabetes mellitus screening and diagnostic criteria Guidelines Year Approach GCT GCT Glucose Threshold OGTT OGTT Glucose Threshold Values GDM Diagnosis Fasting 1-h 2-h 3-h One-step approaches International Association of Diabetes and Pregnancy Study Group (IADPSG) [48] 2010 1-step – – 75-g 5.”
MethodInfluentialNew Consensus Criteria for GDM
Moses, R. G. (2010) · Diabetes Care · doi:10.2337/dc09-2306 · Cited by 60
Consequences of Gestational Diabetes in an Urban Hospital in Viet Nam: A Prospective Cohort Study
Hirst, J. E., Tran, T. S., Do, M. A. T., Morris, J. M., & Jeffery, H. E. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001272 · Cited by 59
“Given current international controversy over the optimal diagnostic criteria to use in order to prevent complications from GDM, we compared outcomes in women and their babies diagnosed with GDM by the American Diabetes Association (ADA) 2010 criterion [14] to outcomes for the additional women and babies that would be…”
BackgroundResultInfluentialChakera, A. J., Carleton, V. L., Ellard, S., Wong, J., Yue, D. K., Pinner, J. R., Hattersley, A. T., & Ross, G. P. (2012) · Diabetes Care · doi:10.2337/dc12-0151 · Cited by 59
Wang, Y., Zhao, X., Zhao, H., Ding, H., Tan, J., Chen, J., Zhang, R., Azziz, R., & Yang, D. (2013) · BioMed Research International · doi:10.1155/2013/182582 · Cited by 57
“In addition, changing diagnostic criteria for GDM and more strict glucose monitoring may affect the incidence of adverse pregnancy outcomes [9, 10].”
BackgroundTriunfo, S., Lanzone, A., & Lindqvist, P. G. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0696-9 · Cited by 61
The Placental Microbiota Is Altered among Subjects with Gestational Diabetes Mellitus: A Pilot Study
Zheng, J., Xiao, X., Zhang, Q., Mao, L., Yu, M., Xu, J., & Wang, T. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00675 · Cited by 59
“GDM was diagnosed when the fasting plasma glucose ≥5.1 mmol/L or 1 h post-OGTT glycemia ≥10.0 mmol/L or 2 h post-OGTT glycemia ≥8.5 mmol/L, according to the criteria set by International Association of Diabetes and Pregnancy Study Groups (IADPSG) (Metzger et al., 2010; American Diabetes Association, 2014).”
MethodInfluentialVitamin D and Gestational Diabetes Mellitus: Is There a Link?
Rizzo, G., Garzon, S., Fichera, M., Panella, M. M., Catena, U., Schiattarella, A., FRANCISCIS, P. D., Vilos, G. A., Tesařík, J., Török, P., et al. (2019) · Antioxidants · doi:10.3390/antiox8110511 · Cited by 69
Moon, J. H., Kwak, S. H., Jung, H. S., Choi, S. H., Lim, S., Cho, Y. M., Park, K. S., Jang, H. C., & Cho, N. H. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1113 · Cited by 58
Sørensen, A. E., van Poppel, M. N. M., Desoyé, G., Damm, P., Simmons, D. S., Jensen, D., Dalgaard, L. T., & The DALI Core Investigator Group (2021) · Cells · doi:10.3390/cells10010170 · Cited by 67
Chen, L., Soh, S. E., Tint, M., Loy, S. L., Yap, F. K. P., Tan, K. H., Lee, Y. S., Shek, L. P., Godfrey, K. M., Gluckman, P. D., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82789-x · Cited by 70
Hiersch, L., Shah, B. R., Berger, H. M., Geary, M. P., McDonald, S. D., Murray‐Davis, B., Halperin, I. J., Retnakaran, R. R., Barrett, J. F. R., & Melamed, N. (2021) · Diabetes Care · doi:10.2337/dc21-0659 · Cited by 62
Lai, M., Weng, J., Yang, J., Gong, Y., Fang, F., Li, N., Kang, M., Xu, X., & Wang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1174239 · Cited by 62
Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome
Sawada, M., Masuyama, H., Hayata, K., Kamada, Y., Nakamura, K., & Hiramatsu, Y. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0364 · Cited by 56
Infanti, J. J., O’Dea, A., Gibson, I., McGuire, B. E., Newell, J., Glynn, L. G., O’Neill, C., Connolly, S. B., & Dunne, F. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-13 · Cited by 67
Development of Early Adiposity in Infants of Mothers With Gestational Diabetes Mellitus
Logan, K. M., Emsley, R. J., Jeffries, S., Andrzejewska, I., Hyde, M. J., Gale, C., Chappell, K., Mandalia, S., Santhakumaran, S., Parkinson, J. R. C., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0030 · Cited by 57
Thériault, S., Giguère, Y., Massé, J., Girouard, J., & Forest, J. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0537 · Cited by 65
“The suggestion of a uniform and more inclusive onestep strategy for screening and diagnosis of GDM by the IADPSG [4] has raised the issue of allocating limited resources to the women who will benefit most.”
BackgroundClustering of metabolic risk factors and adverse pregnancy outcomes: a prospective cohort study
Lei, Q., Niu, J., Lv, L., Duan, D., Wen, J., Lin, X., Mai, C., & Zhou, Y. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2803 · Cited by 68
Gestational diabetes mellitus: A pragmatic approach to diagnosis and management
Nankervis, A., Price, S., & Conn, J. (2018) · Australian Journal of General Practice · doi:10.31128/ajgp-01-18-4479 · Cited by 59
Vinter, C. A., Tanvig, M. H., Christensen, M. H., Ovesen, P. G., Jørgensen, J. S., Andersen, M. S., McIntyre, H. D., & Jensen, D. M. (2018) · Diabetes Care · doi:10.2337/dc18-0808 · Cited by 57
Cvitic, S., Novakovic, B., Gordon, L., Ulz, C., Mühlberger, M., Díaz-Pérez, F., Joo, J. E., Švendová, V., Schimek, M. G., Trajanoski, S., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4699-7 · Cited by 61
Bianchi, C., Gennaro, G., Romano, M., Aragona, M., Battini, L., Prato, S. D., & Bertolotto, A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.08.019 · Cited by 68
Hu, J., Oken, E., Aris, I. M., Lin, P. D., Ma, Y., Ding, N., Gao, M., Wei, X., & Wen, D. (2019) · Nutrients · doi:10.3390/nu11020405 · Cited by 62
Furse, S., White, S. L., Meek, C. L., Jenkins, B., Petry, C. J., Vieira, M. C., Ozanne, S. E., Dunger, D. B., Poston, L., & Koulman, A. (2019) · Molecular Omics · doi:10.1039/c9mo00117d · Cited by 62
Metabolomic profile of term infants of gestational diabetic mothers
Dani, C., Bresci, C., Berti, E., Ottanelli, S., Mello, G., Mecacci, F., Breschi, R., Hu, X., Tenori, L., & Luchinat, C. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.823941 · Cited by 62
Circulating fatty acids and risk of gestational diabetes mellitus: prospective analyses in China
Pan, X.-F., Huang, Y., Li, X., Wang, Y., Ye, Y., Chen, H., Marklund, M., Wen, Y., Liu, Y., Zeng, H., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0118 · Cited by 57
Seasonal Changes in the Prevalence of Gestational Diabetes Mellitus
Moses, R. G., Wong, V. C. K., Lambert, K., Morris, G. J., & San Gil, F. (2016) · Diabetes Care · doi:10.2337/dc16-0451 · Cited by 57
D’Anna, R., Corrado, F., Loddo, S., Gullo, G., Giunta, L., & Di Benedetto, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-88329-x · Cited by 54
Li, H., Miao, C., Liu, W., Gao, H., Li, W., Wu, Z., Cao, H., & Zhu, Y. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s378964 · Cited by 57
Yan, M., Guo, X., Ji, G., Huang, R., Huang, D., Li, Z., Zhang, D., Chen, S., Cao, R., Yang, X., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1097853 · Cited by 59
Guo, Y., Lu, J., Bahani, M., Ding, G., Wang, L., Zhang, Y., Zhang, H., Liu, C., Zhou, L., Liu, X., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02076-2 · Cited by 57
“These criteria are consistent with the latest guidelines from the International Association of the Diabetes and Pregnancy Study Groups [20].”
MethodO’Dea, A., Tierney, M., McGuire, B. E., Newell, J., Glynn, L. G., Gibson, I., Noctor, E., Danyliv, A., Connolly, S. B., & Dunne, F. (2015) · Journal of Diabetes Research · doi:10.1155/2015/798460 · Cited by 71
Yeral, M. İ., Ozgu-Erdinc, A. S., Uygur, D., Seçkin, K. D., Karslı, M. F., & Danışman, A. N. (2013) · Endocrine · doi:10.1007/s12020-013-0111-z · Cited by 62
“The International Association of Diabetes and Pregnancy Study Groups (IADPSG) and American Diabetes Association (ADA) recommended a simplified ‘‘one-step’’ approach to the screening and diagnosis of GDM with 75 g glucose tolerance test (GTT) [1, 6].”
BackgroundMethodInfluentialKennelly, M. A., Ainscough, K. M., Lindsay, K. L., Gibney, E. R., Carthy, M. M., & McAuliffe, F. M. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.11.018 · Cited by 63
Abalos, E. J., Chamillard, M., Díaz, V., Tunçalp, Ö., & Gülmezoglu, A. M. (2015) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13820 · Cited by 73
Santamaria, A., Alibrandi, A., Benedetto, A. D., Pintaudi, B., Corrado, F., Facchinetti, F., & D’Anna, R. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.05.018 · Cited by 61
Gestational Diabetes Mellitus Reduces Breastfeeding Duration: A Prospective Cohort Study
Nguyen, P. T. H., Binns, C. W., Nguyen, C. L., Ha, A. V. V., Chu, T. K., Duong, D., Do, D. V., & Lee, A. H. (2018) · Breastfeeding Medicine · doi:10.1089/bfm.2018.0112 · Cited by 61
Benhalima, K., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., Block, C. E. M. D., et al. (2020) · Acta Diabetologica · doi:10.1007/s00592-019-01469-5 · Cited by 61
Carroll, X., Liang, X., Zhang, W., Zhang, W., Liu, G., Turner, N., & Leeper-Woodford, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-26412-6 · Cited by 56
Juan, J., Sun, Y., Wei, Y., Wang, S., Song, G., Yan, J., Zhou, P., & Yang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1012244 · Cited by 56
Different strategies for diagnosing gestational diabetes to improve maternal and infant health
Farrar, D., Duley, L., Medley, N., & Lawlor, D. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007122.pub3 · Cited by 56
High Folate, Perturbed One-Carbon Metabolism and Gestational Diabetes Mellitus
Williamson, J. M., Arthurs, A. L., Smith, M. D., Roberts, C. T., & Jankovic-Karasoulos, T. (2022) · Nutrients · doi:10.3390/nu14193930 · Cited by 56
Frequency of gestational diabetes mellitus using DIPSI criteria, a study from Pakistan
Riaz, M., Nawaz, A., Masood, S. N., Fawwad, A., Basit, A., & Shera, A. S. (2018) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2018.06.003 · Cited by 56
Cubillos, G., Mönckeberg, M., Plaza, A., Morgan, M., Estévez, P. A., Choolani, M. A., Kemp, M. W., Illanes, S. E., & Perez, C. A. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05766-4 · Cited by 63
“A diagnosis of GDM was made using the IADPSG/HAPO criteria for gestational diabetes [13, 39], i.e., oral glucose tolerance test (75 g) fasting glycemia ≥ 92 mg/dl, or 2 h glycemia ≥ 153 mg/dl in the second trimester.”
BackgroundMethodNobles, C. J., Markenson, G. R., & Chasan‐Taber, L. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515003980 · Cited by 62
Gao, J., Xu, B., Zhang, X., Cui, Y. J., Deng, L., Shi, Z., Shao, Y., & Ding, M. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.05.026 · Cited by 60
Dugas, C., Perron, J., Kearney, M., Mercier, R., Tchernof, A., Marc, I., Weisnagel, S. J., & Robitaille, J. (2017) · Obesity Facts · doi:10.1159/000477407 · Cited by 63
Gallagher, D., Rosenn, B., Toro‐Ramos, T., Paley, C., Gidwani, S., Horowitz, M., Crane, J., Lin, S. X., Thornton, J. C., & Pi-Sunyer, X. (2018) · Obesity · doi:10.1002/oby.22079 · Cited by 57
Diabesity-associated oxidative and inflammatory stress signalling in the early human placenta
Hoch, D., Gauster, M., Mouzon, S. H., & Desoyé, G. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.11.002 · Cited by 63
Okesene-Gafa, K. A., Moore, A. E., Jordan, V., McCowan, L., & Crowther, C. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012970.pub2 · Cited by 53
Vitale, S. G., Corrado, F., Caruso, S., Benedetto, A. D., Giunta, L., Cianci, A., & D’Anna, R. (2020) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2020.1852191 · Cited by 57
“…Coustan 1982), was the most considered in Western countries until 8 years ago, when the International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel (Metzger et al. 2010), on the basis of the HAPO study results (Metzger et al. 2008), recommended new diagnostic criteria.”
BackgroundInfluentialDietary patterns and associations between air pollution and gestational diabetes mellitus
Hehua, Z., Yang, X., Chang, Q., Shanyan, G., & Yuhong, Z. (2020) · Environment International · doi:10.1016/j.envint.2020.106347 · Cited by 62
Occurrence and recurrence of diabetes in pregnancy
Khambalia, A. Z., Ford, J. B., Nassar, N., Shand, A. W., McElduff, A., & Roberts, C. L. (2013) · Diabetic Medicine · doi:10.1111/dme.12124 · Cited by 55
Tieu, J., McPhee, A. J., Crowther, C. A., & Middleton, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007222.pub3 · Cited by 32
Padmanabhan, S., Lee, V. W., Mclean, M., Athayde, N., Lanzarone, V., Khoshnow, Q., Peek, M. J., & Cheung, N. W. (2017) · Diabetes Care · doi:10.2337/dc17-0391 · Cited by 55
Wu, E., Nien, F., Kuo, C., Chen, S., Chen, K., Chuang, L., Li, H., & Lee, C. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12378 · Cited by 55
Characteristics of gestational diabetes subtypes classified by oral glucose tolerance test values
Kotzaeridi, G., Blätter, J., Eppel, D., Rosicky, I., Linder, T., Geissler, F., Huhn, E. A., Hösli, I., Tura, A., & Göbl, C. S. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13628 · Cited by 55
Monod, C., Kotzaeridi, G., Linder, T., Eppel, D., Rosicky, I., Filippi, V., Tura, A., Hösli, I., & Göbl, C. S. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-02011-w · Cited by 66
Intergenerational transmission of insulin resistance and type 2 diabetes
Poston, L. (2010) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2010.11.011 · Cited by 59
Lindqvist, M., Persson, M., Lindkvist, M., & Mogren, I. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-185 · Cited by 55
“%) of Swedish pregnant women were exposed to a screening regime for diagnosing GDM at a 2-hour plasma glucose of 8.9 mmol/L, which is higher than the cut-off value of 8.5 mmol/L recommended by IADPSG and WHO [17,18].”
MethodInfluentialRenault, K. M., Carlsen, E. M., Nørgaard, K., Nilas, L., Pryds, O. A., Secher, N. J., Cortes, D., Jensen, J. B., Olsen, S. F., & Halldorsson, T. I. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.110551 · Cited by 62
“On the basis of the results of the HAPO study, revised criteria for the diagnosis of gestational diabetes mellitus (GDM) were proposed by the International Association of Diabetes and Pregnancy Study Groups (9) in 2010.”
Alberico, S., Erenbourg, A., Hod, M., Yogev, Y., Hadar, E., Neri, F., Ronfani, L., Maso, G., & the GINEXMAL Group (2017) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14389 · Cited by 52
Tawfeek, M., Alfadhli, E. M., Alayoubi, A. M., El-Beshbishy, H. A., & Habib, F. (2017) · BMC Women s Health · doi:10.1186/s12905-017-0373-3 · Cited by 58
“The diagnosis of GDM in Ohud hospital is based on the international Association of Diabetes and Pregnancy Study Groups (IADPSG) consensus panel [12].”
MethodHao, M., & Lin, L. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0359 · Cited by 58
Better decision making in preventive health screening: Balancing benefits and harms.
Bell, N. R., Grad, R. M., Dickinson, J. A., Singh, H., Moore, A. E., Kasperavicius, D., & Kretschmer, K. L. (2017) · Europe PMC (PubMed Central) · Cited by 77
Kurdi, A. M., Majeed‐Saidan, M. A., Rakaf, M. S. A., Alhashem, A. M., Botto, L. D., Ba’aqeel, H., & Ammari, A. N. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026351 · Cited by 55
Chivese, T., Norris, S. A., & Levitt, N. S. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002865 · Cited by 54
Pregnancy-Related Extracellular Vesicles Revisited
Condrat, C. E., Varlas, V. N., Duică, F., Antoniadis, P., Dănilă, C. A., Crețoiu, D., Suciu, N., Creţoiu, S. M., & Voinea, S. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083904 · Cited by 56
Renz, P. B., Chume, F. C., Timm, J. R. T., Pimentel, A. L., & Camargo, J. L. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-1191 · Cited by 54
“study [6], with a pre-test probability of 18% for GDM and the PLR and NLR”
Hromadníková, I., Kotlabová, K., Dvořáková, L., & Krofta, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072437 · Cited by 55
Zeng, Y., Li, Y., Yin, X., & Zhao, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1241372 · Cited by 56
Xia, T., He, W., Luo, Z., Wang, K., & Tan, X. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132256 · Cited by 64
Sugiyama, T., Saito, M., Nishigori, H., Nagase, S., Yaegashi, N., Sagawa, N., Kawano, R., Ichihara, K., Sanaka, M., Akazawa, S., et al. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.020 · Cited by 61
Normal fasting plasma glucose levels during pregnancy: a hospital-based study
Riskin-Mashiah, S., Damti, A., Younes, G., & Auslander, R. (2011) · Journal of Perinatal Medicine · doi:10.1515/jpm.2010.142 · Cited by 53
Sommer, C., Sletner, L., Mørkrid, K., Jenum, A. K., & Birkeland, K. I. (2015) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-015-0512-5 · Cited by 56
“Despite a strong focus on maternal glycemia after the HAPO study and the proposed new criteria for gestational diabetes [22], few studies have explored the effects of glucose and lipid levels on the newborn’s anthropometrics independently of gestational weight gain.”
Background2D-DIGE to identify proteins associated with gestational diabetes in omental adipose tissue
Oliva, K., Barker, G., Rice, G. E., Bailey, M. J., & Lappas, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0010 · Cited by 57
Delivery modes and pregnancy outcomes of low birth weight infants in China
Chen, Y., Wu, L., Zhang, W., Zou, L., Li, G., & Fan, L. (2015) · Journal of Perinatology · doi:10.1038/jp.2015.137 · Cited by 58
Metadata
- Authors
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Corresponding author
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-03-01
- Volume
- 33
- Issue
- 3
- Pages
- 676-682
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2827530
- OpenAlex
- W2616235706
- Cited by
- 5,390
- References
- 56
- Citations by year
- 2026: 314 · 2025: 377 · 2024: 446 · 2023: 423 · 2022: 494 · 2021: 507 · 2020: 425 · 2019: 350 · 2018: 367 · 2017: 297 · 2016: 274 · 2015: 296 · 2014: 235 · 2013: 203 · 2012: 167
- FWCI
- 250.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- American Diabetes Association
- Kaiser Permanente
- National Institute of Child Health and Human Development (R01‐HD34242, R01-HD-34243)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD-34243, R01-HD-34242, R01HD034242, R01HD034243)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, hyperglycemia in pregnancy, IADPSG criteria, perinatal outcomes, maternal glycemia, diagnostic thresholds
- MeSH terms
- Female, Health Planning Guidelines, Humans, Hyperglycemia, International Cooperation, Pregnancy, Pregnancy Complications, Pregnancy in Diabetics, Societies, Medical, Diabetes, Gestational, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.